Baijin Life Science (1466) Announces Board Lot Reduction to 8,000 Shares Effective December 2025

Bulletin Express
Nov 17

Baijin Life Science Holdings Limited (stock code: 1466) has announced a change in the board lot size for its shares, reducing each lot from 32,000 shares to 8,000 shares. According to the announcement, the adjustment will become effective at 9:00 a.m. on Monday, 8 December 2025.

Based on the latest closing price of HK$0.53 per share, the market value of the current board lot of 32,000 shares stands at HK$16,960. Following the board lot size reduction, each new lot of 8,000 shares is valued at HK$4,240. The company expects this move to facilitate trading by lowering the threshold for investors, potentially enhancing liquidity and broadening the shareholder base.

According to the timetable, the first day for free exchange of existing share certificates (in lots of 32,000 shares) for new certificates (in lots of 8,000 shares) will begin on Monday, 24 November 2025. The last day for trading in the old lots will be Friday, 5 December 2025, with parallel trading in both old and new board lots running until Tuesday, 30 December 2025. Shareholders have until 4:30 p.m. on Friday, 2 January 2026, to exchange their certificates free of charge.

The company states that shareholders’ rights remain unaffected by the change, and no odd lot arrangement is required other than those that may already exist. Shareholders are advised to refer directly to the official announcement for the complete details, including the schedule and share certificate exchange procedures.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10